Chief Medical Officer

Exclusive: Charles Fuchs departs Roche to become Chief Medical Officer at Tubulis, steering ADC pipeline after $401M Series C

2 weeks ago talkbio0Tagged Antibody-Drug Conjugates, Cambridge office, Charles Fuchs, Chief Medical Officer, genentech, Hematology (discipline), NaPi2b, Neoplasms, pipeline, Roche (company), Series C financing, Solid Neoplasm, therapeutic autologous dendritic cells, TPBG gene, TUB-030, TUB-040, Tubulis

Charles Fuchs; Tubulis; Roche; Genentech; chief medical officer; antibody-drug conjugates; ADC pipeline; TUB-040; TUB-030; Series C financing; oncology; hematology; solid tumors; NaPi2b; 5T4; Cambridge office

QuanBio Appoints Aubrey C. Galloway, MD, as Chief Medical Officer

3 weeks ago talkbio0Tagged AI-driven, Aubrey C. Galloway, Cardiothoracic surgery specialty, Chief Medical Officer, CMO appointment, Healthcare technology, Leadership Change, medical leadership, QuanBio, Vascular Diseases, vascular intelligence

QuanBio; Aubrey C. Galloway; Chief Medical Officer; CMO appointment; AI-driven vascular intelligence; cardiothoracic surgery; leadership change; healthcare technology; vascular disease; medical leadership

Galecto Announces Key Additions to Leadership Team

3 weeks ago talkbio0Tagged Becker Hewes, Chief Medical Officer, Chief Operating Officer, DMR-001, Galecto, Sherwin Sattarzadeh

Galecto; Sherwin Sattarzadeh; Becker Hewes; Chief Operating Officer; Chief Medical Officer; DMR-001; mutCALR

Genelux Corporation Appoints Jason Litten, M.D., as Chief Medical Officer to Advance Olvi-Vec Development

3 weeks ago talkbio0Tagged Chief Medical Officer, Chronic multifocal osteomyelitis, Clinical Trials, Genelux Corporation, immuno-oncology, Jason Litten

Genelux Corporation; Jason Litten; Chief Medical Officer; CMO; Olvi-Vec; immuno-oncology; clinical trials

Alkeus Pharmaceuticals Appoints Carlos Quezada-Ruiz as Chief Medical Officer

2 months ago talkbio0Tagged Alkeus, Biological Factors, Carlos Quezada-Ruiz, Chief Medical Officer, Clinical Research, gildeuretinol, Ophthalmology specialty, Retinal Diseases, Stargardt's disease

Alkeus Pharmaceuticals; Carlos Quezada-Ruiz; Chief Medical Officer; Stargardt disease; gildeuretinol; retinal diseases; ophthalmology; clinical research; biopharmaceutical leadership

Whitehawk Therapeutics Appoints Margaret Dugan as Chief Medical Officer

2 months ago talkbio0Tagged Chief Medical Officer, Chronic multifocal osteomyelitis, Clinical Trials, Dracen Pharmaceuticals, Drug Development, Margaret Dugan, Neoplasms, Novartis, Schrödinger, therapeutic autologous dendritic cells, Whitehawk Therapeutics

Whitehawk Therapeutics; Margaret Dugan; Chief Medical Officer; CMO; oncology; ADC; drug development; clinical trials; Novartis; Dracen Pharmaceuticals; Schrödinger

Syndeio Biosciences Appoints Aaron Koenig, M.D., as Chief Medical Officer (CMO)

3 months ago talkbio0Tagged Aaron Koenig, Alzheimer 's disease, Chief Medical Officer, Clinical Trials, CNS disorder, neuropsychiatric, neuroscience drug development, synaptic health, Syndeio Biosciences, zelquistinel

Syndeio Biosciences; Aaron Koenig; Chief Medical Officer; CNS disorders; synaptic health; neuroscience drug development; zelquistinel; Alzheimer’s disease; neuropsychiatric; clinical trials